[HTML][HTML] Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
UM Rudolph, S Enners, M Kieble, F Mahfoud… - Journal of Human …, 2021 - nature.com
In Germany,~ 8 million patients take angiotensin receptor blockers (ARBs) and 2.25 million
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
UM Rudolph, S Enners, M Kieble… - Journal of Human …, 2021 - refubium.fu-berlin.de
In Germany, similar to 8 million patients take angiotensin receptor blockers (ARBs) and 2.25
million of them valsartan. In 2018, contamination of generic ARBs with probable …
million of them valsartan. In 2018, contamination of generic ARBs with probable …
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany.
UM Rudolph, S Enners, M Kieble… - Journal of Human …, 2021 - opus.lib.uts.edu.au
In Germany,~ 8 million patients take angiotensin receptor blockers (ARBs) and 2.25 million
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
UM Rudolph, S Enners, M Kieble… - Journal of human …, 2021 - pubmed.ncbi.nlm.nih.gov
In Germany,~ 8 million patients take angiotensin receptor blockers (ARBs) and 2.25 million
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany.
UM Rudolph, S Enners, M Kieble… - Journal of Human …, 2020 - europepmc.org
In Germany,~ 8 million patients take angiotensin receptor blockers (ARBs) and 2.25 million
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
[PDF][PDF] Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
UM Rudolph, S Enners, M Kieble… - Journal of Human …, 2021 - academia.edu
In Germany,~ 8 million patients take angiotensin receptor blockers (ARBs) and 2.25 million
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
[HTML][HTML] Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
UM Rudolph, S Enners, M Kieble… - Journal of Human …, 2021 - ncbi.nlm.nih.gov
In Germany,~ 8 million patients take angiotensin receptor blockers (ARBs) and 2.25 million
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
[PDF][PDF] Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
UM Rudolph, S Enners, M Kieble… - Journal of Human …, 2021 - opus.lib.uts.edu.au
In Germany,~ 8 million patients take angiotensin receptor blockers (ARBs) and 2.25 million
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …
of them valsartan. In 2018, contamination of generic ARBs with probable carcinogenic …